Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-261722
Filing Date
2024-11-19
Accepted
2024-11-19 16:05:58
Documents
1
Group Members
ASGARD INVESTMENT CORP. IICLINT D. CARLSONDOUBLE BLACK DIAMOND OFFSHORE LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d912959dsc13ga.htm SC 13G/A 79795
  Complete submission text file 0001193125-24-261722.txt   81573
Mailing Address 2100 MCKINNEY AVE STE 1900 DALLAS TX 75201
Business Address 2100 MCKINNEY AVE STE 1900 DALLAS TX 75201 2149329600
Carlson Capital, L.P. (Filed by) CIK: 0001056973 (see all company filings)

EIN.: 752494317 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Subject) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91311 | Film No.: 241476039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)